Q&A with Per Wickstrom on The War between Pharma Stock and Holistic Solutions

In recent years there has been a great deal of controversy surrounding the large pharmaceutical companies and their push to get consumers to take the medications they manufacture and sell for, oftentimes, exorbitant prices. However, in recent news, this issue was brought into the spotlight when Turing Pharmaceuticals AG bought the rights in the United States to an anti-parasitic drug called Daraprim. According to news sources, it isn’t actually the buying of the rights that has doctors, pharmacists, an assortment of medical professionals and consumers up in arms, but rather the excessive price hike that has everyone ready to do … Continue reading Q&A with Per Wickstrom on The War between Pharma Stock and Holistic Solutions